News AstraZeneca changes contractors as HQ delayed again AstraZeneca has switched building contractors in a bid to hasten progress on its delayed and over-budget new headquarters, which is under construction in Cambridge.
News Serial entrepreneur Huntingdon raises funds for latest biote... Z Factor, a University of Cambridge spin-out company has raised £7 million in a Series A investment
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.